## Core Concept
Neonatal tetanus elimination is validated based on the achievement of a very low incidence of neonatal tetanus cases, typically less than 0.1 per 1000 live births per year, in a given area. This validation is part of global efforts to reduce and eliminate tetanus, particularly in areas with high birth rates and limited access to healthcare.

## Why the Correct Answer is Right
The correct answer, , implies that as of 2007, neonatal tetanus elimination had not been validated in this particular state. Without specific details on the states listed (A, B, C, D), we rely on the understanding that validation of neonatal tetanus elimination requires rigorous surveillance and a demonstrated significant reduction in neonatal tetanus cases. States or regions that have not achieved this criterion by 2007 would be those still struggling with higher incidence rates or with challenges in reporting and verifying cases.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it is stated that neonatal tetanus elimination has been validated in these states as of 2007, implying they have met the necessary criteria for elimination.
- **Option B:** Similarly, this option is incorrect for the same reason as Option A; these states have achieved validation for neonatal tetanus elimination.
- **Option C:** This option is also incorrect as it represents another state where neonatal tetanus elimination has been validated.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the elimination of neonatal tetanus is a critical milestone in public health, particularly in regions with high maternal and neonatal mortality. It reflects not only the effectiveness of tetanus toxoid vaccination programs for pregnant women but also the overall improvement in healthcare access and quality.

## Correct Answer Line
**Correct Answer: D.**